Sautter F, McDermott B, Garver D
Department of Psychiatry and Neurology, Tulane University School of Medicine, New Orleans, LA 70112.
Biol Psychiatry. 1993 Jan 1;33(1):15-21. doi: 10.1016/0006-3223(93)90273-g.
Recent data suggest that latency of neuroleptic response may be used to separate distinct subtypes of psychotic disorders. In this preliminary study we contrast family patterns of illness of rapid neuroleptic response psychotics and delayed neuroleptic response psychotics. The data show that first-degree relatives of delayed neuroleptic response psychotics evidence higher levels of psychiatric disorder than rapid responders: relatives of delayed neuroleptic response psychotics evidenced a morbid risk for schizophrenic-spectrum disorder that was more than twice as high as the morbid risk for such disorders among relatives of rapid neuroleptic response psychotics. Relatives of delayed neuroleptic responders that received a diagnosis of schizophrenia, schizoaffective, or schizophreniform disorder evidenced significantly more residual impairment than schizophrenic-spectrum relatives of rapid neuroleptic responders. These preliminary data indicate the possibility that latency of therapeutic response to neuroleptic medication may be used to discriminate two familially distinct psychotic disorders and they suggest that delayed neuroleptic response may characterize a familially transmitted poor-outcome disease.
近期数据表明,抗精神病药物反应的潜伏期可用于区分不同亚型的精神障碍。在这项初步研究中,我们对比了抗精神病药物快速反应型精神病患者和抗精神病药物延迟反应型精神病患者的家族疾病模式。数据显示,抗精神病药物延迟反应型精神病患者的一级亲属出现精神障碍的水平高于快速反应者:抗精神病药物延迟反应型精神病患者的亲属患精神分裂症谱系障碍的患病风险是抗精神病药物快速反应型精神病患者亲属的两倍多。被诊断为精神分裂症、分裂情感性障碍或精神分裂症样障碍的抗精神病药物延迟反应者的亲属,其残留损害明显多于抗精神病药物快速反应者的精神分裂症谱系亲属。这些初步数据表明,抗精神病药物治疗反应的潜伏期有可能用于区分两种家族性不同的精神障碍,并且表明抗精神病药物延迟反应可能是一种家族遗传性预后不良疾病的特征。